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Dabigatran is a new oral direct thrombin inhibitor and has been
proposed to overcome many pitfalls of warfarin therapy.
Method: In this study, we retrospectively studied 236 patients who
had atrial ﬁbrillation and were at risk of stroke who received ﬁxed
dose of Dabigatran 110 mg and adjusted-dose warfarin. Patients
were followed up for a period of 2 years and stroke or systemic
embolism was our primary end points.
Results: When rates of the primary outcome were considered
which was 1.56% per year in the warfarin group, as compared with
1.33% per year in the group that received 110 mg of dabigatran
(relative risk with dabigatran, 0.90; 95% conﬁdence interval [CI],
0.72–1.09; p < 0.001 for non inferiority). Again the rate of major
bleeding was 2.96% per year in the warfarin group, as compared
with 2.11% per year in the group receiving 110 mg of dabigatran
( p = 0.005). If the rate of hemorrhagic stroke was considered, it was
0.34% per year in the warfarin group, as compared with 0.09% per
year with 110 mg of dabigatran ( p < 0.003). Finally the mortality
rate was 3.9% per year in the warfarin group, as compared with
3.15% per year with 110 mg of dabigatran ( p = 0.11)
Conclusions:We observed in our study that, dabigatran given at a
dose of 110 mg was associated with rates of stroke and systemic
embolism that were similar and were non inferior to those asso-
ciated with warfarin, as well as lower rates of major hemorrhage.
Alsomany pitfalls of warfarinwere coveredwell by Dabigatran and
hence it's use in patients of atrial ﬁbrillation with risk of stroke can
be advocated.
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Inmicamineworkers in Nellore district the prevalence of ischemic
heart disease and serum cholesterol levels are less in when com-
pared to other rural population in our earlier studies. Vanadium
content of mica and Blood levels of vanadium in mica workers is
high compared to other rural population. Hence study in experi-
mental animals is under taken in our laboratory to know the effect
of vanadium.
Vanadium is an essential trace elements in certain animals and its
role in humans is debated. Under physiological conditions vana-
dium predominantly exists in either an anionic form (vanadate) or
a cationic form vanadyl. The vanadate is mainly bound to trans-
ferin and to a lesser extent to albumin. The present study aimed to
know the effect of vanadium supplementation on high fat diet
induced hyperlipidemia in experimental animals. In this study,
New Zealand white breed male rabbits divided into three groups
and each group consists of 6 in number.
Group I: Rabbits fed with standard diet.
Group II: Fed with 2% cholesterol diet.
Group III: Rabbits fed with group II diet and supplemented with
0.75 mg/kg of elemental vanadium as Sodium meta vanadate.
Total cholesterol, LDL cholesterol and triglycerides were signiﬁ-
cantly decreased in Group III when compared to Group II after the
experiment. HDL is similar in both groups. Present study shows
antilipedemic effect of Vanadium in experimental rabbits. Supple-
mentation of vanadiummay prevent cardiovascular risk factor like
Hyperlipidemia.
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Introduction: ST2 is a biomarker which is a member of the inter-
leukin (IL)-1 receptor family and exists in two forms, a trans-
membrane receptor (ST2L) as well as a soluble decoy receptor
(sST2). Myocytes that are subjected to mechanical stress secrete
ST2, that is associated with HF after STEMI.
Aims & objectives: To co-relate the level of ST2 on presentation
and at discharge, with the clinical severity of the disease on
presentation, the subsequent complications of ACS during the
hospital stay and the occurrence of heart failure/adverse cardio-
vascular events (re-infarction/death) after discharge.
Inclusion & exclusion criteria:
1. Age more than 30 years.
2. Presenting within 24 hours of onset of symptoms.
3. Fulﬁlling the criteria for diagnosis of Acute MI.
4. Patients with PCI related and CABG related acute MI have been
excluded.
Materials and methods: A prospective study is being done in
patients admitted with ACS in Apollo hospital Chennai. Blood
samples for ST2 are taken on presentation & at discharge. The
sample is analysed using the 'Presage kit' provided by Critical
diagnostics-Chennai Medipoint. A cut off of 35 ng/dl was used to
label a sample as high ST2 level. Clinical history, biochemical tests
and Echocardiography results are also documented.
Results: 42 patients admitted in Apollo Hospital, Chennai have
been included so far. The clinical proﬁle, ST2 levels, the clinical
outcome and re-hospitalisations (if any) were documented.
Conclusion: The study is still in process and concrete conclusions
cannot be drawn based on the existing samples. However high ST2
values were seen to be associated with increased mortality.
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Introduction: Cardiovascular (CV) involvement is common and a
signiﬁcant cause of morbidity and mortality in systemic lupus
erythematosus (SLE). Auto-antibodies anti-dsDNA and antipho-
spholipids antibodies (APLA) are both pathogenic as well as serve
a role as biomarker for diagnosis and severity. There are only very
few reports of correlation of anti-dsDNA and/or APLA positivity
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with cardiovascular manifestations in SLE, especially in Indian
subjects.
Aims and methods: The study aimed to characterize the cardio-
vascular manifestations of SLE and correlate them with anti-
dsDNA and APLA positivity. Anti-ds DNA was assayed by immu-
noﬂourescence staining on Hep-2 cells and APLAwasmeasured by
both liquid phase (lupus anticoagulant) ELISA and solid phase (anti
cardiolipin) ELISA assays.
Results: All the study subjects (n = 30) were females with a mean
age of 23.07 years. Themost frequent CVmanifestation was that of
pericardial involvement occurring in 63.3% (n = 19) patients. Valve
thickening or regurgitation (46.6%), myocarditis (13.3%) and pul-
monary artery hypertension (20%) were the other major CV invol-
vements in SLE. Serological assay revealed 83.3% (n = 25) positivity
for anti-ds DNA, while APLA was positive in 36.7% (n = 11) of the
patients. APLA was found to be signiﬁcantly associated with valv-
ular heart disease ( p = 0.0295). APLA also had signiﬁcant associa-
tionswith increased pulmonary artery systolic pressure ( p < 0.001)
andmyocarditis ( p = 0.005). Anti ds DNAwas not found to have any
signiﬁcant association with either valvular heart disease
( p = 0.102), myocarditis or pulmonary artery hypertension but
was signiﬁcantly associated with pericarditis ( p = 0.028).
Conclusions: As observed in western series, APLA were signiﬁ-
cantly associated with valvular heart disease in SLE in our series;
although in contrast, pericarditis was more prevalent in anti
dsDNA positive than negative patients. This study results could
prompt early echocardiographic examinations in patientswith SLE
and APLA positivity, and invite larger studies to establish patho-
genic role of these antibodies.
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Background: Increased QT dispersion (QTd) occurs in some cases
of Diabetes Mellitus (DM) which may increase the risk of serious
ventricular arrhythmia and sudden death. Type 1 DM and Type 2
DMmay differ in incidence of increased QTd. Similarly, there may
be difference in number of patients with increased QTd in con-
trolled and uncontrolled DM in each group.
Methods: 100 cases, each of Type 1 and Type 2 DM and each group
having 50 controlled and 50 uncontrolled cases along with 50 age
and sex matched healthy volunteers comprised material of this
study. In both these groups of Type 1 and Type 2 DM, age, sex and
duration of DM were properly matched. Detailed clinical examina-
tion (with special attention to postural hypotension and resting
tachycardia), relevant biochemical investigations including fasting
and postprandial glucose, HbA1c and ECGs were done in all cases.
In ECG, QTd was meticulously calculated as per guidelines. The
patients with uncontrolled blood glucose and increased HbA1c
were given appropriate treatment. HbA1c was repeated 90 days
after normalization of blood glucose and QTd was again analyzed.
Results:QTdwas increased in 16 cases of Type 1 DM (controlled – 7,
uncontrolled – 9) whereas in 18 cases of Type 2 DM (controlled – 7,
uncontrolled – 11). Postural hypotension and resting tachycardia
were observed in 8 cases of Type 1 DM and 10 cases of Type 2 DM.
After control of blood glucose and HbA1c, ECGs were repeated and
QTd was analyzed. In Type 1 DM, 1 patient from uncontrolled
group and in Type 2 DM, 2 patients from uncontrolled group, after
control of blood glucose and HbA1c showed normalization of QTd.
Conclusions: In the present study, QTdwas increased in both Type
1 DM and Type 2 DM group but in relatively more number of
patients in Type 2 DM group. After control of blood glucose and
HbA1c, 1 patient from Type 1 DM group and 2 patients Type 2 DM
group showed normalization of QTd and this difference was very
slight. This slight difference may be related to higher age of
patients and age related changes in myocardium in Type 2 DM
group. Increase in QTd may be related to cardiac dysautonomia or
due to structural changes in myocardium. Patients with increased
QTd require more attention as it may lead to serious ventricular
arrhythmia and sudden death. However, more studies on large
number of patients are required to conﬁrm these observations and
ﬁnd out their mechanism.
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Background: ECG changes are known in acute stroke and increased
QT dispersion (QTd) is one of them. Increased QTd is associated
with serious ventricular arrhythmia and sudden death.
Methods: 100 cases of acute stroke and 50 age and sex matched
healthy volunteers comprisedmaterial of this study. All caseswere
evaluated within 24 hours of onset of acute stroke. In addition to
neurological assessment, CT/MRI and ECG changes were analyzed.
In 30 out of 100 patients, ECGs were done within 10 hours whereas
in remaining 70 cases, ECGswere done between 10 to 20 hours after
onset of acute stroke as they came late for admission in the
hospital.
Results: These stroke patients had weakness either on one side of
body or in one of the limbs i.e. monoparasis/plegia. 3 patients were
unconscious. CT/MRI revealed lesions in cerebral cortex or brain
stem in the formof hemorrhage, thrombosis or embolism. In 30 out
of 100 patients, ECGs were done within 10 hours whereas in
remaining 70 cases, ECGs were possible only after 10 hours as they
came late for admission in the hospital. QTd was increased in 16
cases out of 70 in which ECGs were done after 10 hours of onset of
stroke. In this group, 13 cases hadmassive stroke (massive hemor-
rhage – 10, massive infarction – 3) which included 3 unconscious
patients mentioned above. In addition, 3 out of 50 healthy volun-
teers also showed increased QTd.
Conclusions: Increased QTdwas observed in 16 cases (including 13
cases of massive stoke) of acute stroke. In all these cases, ECGs
were done after 10 hours of onset of acute stroke. It appears that
early ECG may not be rewarding as increase in QTd occurs little
late. In contrast, only 3 out of 50 healthy volunteers showed
increased QTd. Sudden death in acute stroke may occur due to
increased QTd (and occurrence of serious ventricular arrhythmia)
or due to damage of vital centres in brain. It appears that patients
with increased QTd in stroke may require more medical attention.
If patients of acute stroke with increased QTd are meticulously
monitored, sudden death may be prevented. However, more stu-
dies on large number of cases are required to conﬁrm these
observations and ﬁnd out their mechanism.
Ivabradine versus metoprolol in
patients with acute inferior wall
myocardial infarction – 'Expanding
arena for ivabradine'
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Background: Beta-blockers in ST-segment elevation myocardial
infarction (STEMI) are particularly indicated in patients with high
heart rates (HR) or LV dysfunction. But AV blocks are biggest
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